Patent: 10,144,944
✉ Email this page to a colleague
Summary for Patent: 10,144,944
Title: | Methods of cell culture |
Abstract: | Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using putrescine, are described. |
Inventor(s): | Prentice; Holly (Carlisle, MA) |
Assignee: | Momenta Pharmaceuticals, Inc. (Cambridge, MA) |
Application Number: | 15/496,368 |
Patent Claims: | see list of patent claims |
Details for Patent 10,144,944
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 12/31/2002 | ⤷ Try a Trial | 2033-03-14 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 02/21/2008 | ⤷ Try a Trial | 2033-03-14 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 04/24/2013 | ⤷ Try a Trial | 2033-03-14 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 09/23/2014 | ⤷ Try a Trial | 2033-03-14 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 11/23/2015 | ⤷ Try a Trial | 2033-03-14 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 03/09/2016 | ⤷ Try a Trial | 2033-03-14 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 10/17/2016 | ⤷ Try a Trial | 2033-03-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |